Coronavirus disease 2019 (COVID-19) is a viral infection affecting multiple organ systems of
great significance for metabolic processes. Thus, there is increasing interest in metabolic …

There is an urgent need to identify which COVID-19 patients will develop life-threatening
illness so that medical resources can be optimally allocated and rapid treatment can be …

COVID-19 is mainly associated with respiratory distress syndrome, but a subset of patients
often present gastrointestinal (GI) symptoms. Imbalances of gut microbiota have been …

Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, the gut microbiome
in COVID-19 has garnered substantial interest, given its significant roles in human health …

The interplay between the compositional changes in the gastrointestinal microbiome, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptibility and severity, and …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to
nearly every continent, registering over 1,250,000 deaths worldwide. The effects of SARS …

The intestinal microbiota plays an important role in the immune response against viral
infections, modulating both innate and adaptive immune responses. The cytokine storm is …

Objective To characterise the oral microbiome, gut microbiome and serum lipid profiles in
patients with active COVID-19 and recovered patients; evaluate the potential of the …

Coronavirus disease 2019 (COVID-19) has infected over 60 million people worldwide.
Besides developing the therapeutics and vaccines, the evaluation of sequelae in recovered …

Abstract Coronavirus disease 2019 (COVID-19) has gained prominence as a global
pandemic. Studies have suggested that systemic alterations persist in a considerable …